The difficulty of learning the technology behind mRNA vaccines poses a major obstacle to President Joe Biden’s proposal aiding poor countries by defying the pharmaceutical industry and waiving patent protections for COVID-19 vaccines.

The rationale for the patent waiver would be to allow developing countries to reproduce currently existing COVID-19 vaccines without having to worry about getting sued by the pharmaceutical companies that hold the patents.

Recommended Stories

Pfizer and Moderna stocks tumble over anticipated low COVID-19 vaccination rate

German Chancellor Merkel opposes Biden’s proposed patent waiver for COVID-19 vaccines

Top Biden aide on COVID-19 vaccine to exit post next week